Milestone achieved for Global Anti-Epileptic program

We are happy to congratulate first site-participant of epilepsy trial opened in Russia last month under GCT management. It officially launches the enrollment for the Phase III multinational study in patients with drug-resistant partial-onset seizures.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.